Psychemedics Stock Analysis
PMD Stock | USD 2.54 0.02 0.78% |
Psychemedics is undervalued with Real Value of 2.75 and Hype Value of 2.57. The main objective of Psychemedics stock analysis is to determine its intrinsic value, which is an estimate of what Psychemedics is worth, separate from its market price. There are two main types of Psychemedics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Psychemedics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Psychemedics' stock to identify patterns and trends that may indicate its future price movements.
The Psychemedics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Psychemedics is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Psychemedics Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Psychemedics' ongoing operational relationships across important fundamental and technical indicators.
Psychemedics |
Psychemedics Stock Analysis Notes
About 23.0% of the company outstanding shares are owned by corporate insiders. The book value of Psychemedics was at this time reported as 1.15. The company recorded a loss per share of 0.72. Psychemedics last dividend was issued on the 24th of May 2023. The entity had 1:4 split on the 1st of August 2002. Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. Psychemedics Corporation was incorporated in 1986 and is headquartered in Acton, Massachusetts. Psychemedics operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 1 people. To find out more about Psychemedics contact Brian Hullinger at 978 206 8220 or learn more at https://www.psychemedics.com.Psychemedics Quarterly Total Revenue |
|
Psychemedics Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Psychemedics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Psychemedics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Psychemedics generated a negative expected return over the last 90 days | |
The company reported the last year's revenue of 22.1 M. Reported Net Loss for the year was (4.15 M) with profit before taxes, overhead, and interest of 9.29 M. | |
Psychemedics has about 1.79 M in cash with (1.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.32. | |
Psychemedics has a poor financial position based on the latest SEC disclosures | |
Roughly 23.0% of the company outstanding shares are owned by corporate insiders | |
Latest headline from accesswire.com: PMD Device Solutions Signs Transfer Agreement for Key Assets in Coala-Life Group AB to Accelerate its US Market Entry |
Psychemedics Upcoming and Recent Events
Earnings reports are used by Psychemedics to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Psychemedics previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
19th of March 2024 Upcoming Quarterly Report | View | |
31st of December 2023 Next Fiscal Quarter End | View |
Psychemedics Largest EPS Surprises
Earnings surprises can significantly impact Psychemedics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2009-08-04 | 2009-06-30 | 0.04 | 0.03 | -0.01 | 25 | ||
2014-04-29 | 2014-03-31 | 0.12 | 0.14 | 0.02 | 16 | ||
2010-02-23 | 2009-12-31 | 0.07 | 0.1 | 0.03 | 42 |
Psychemedics Thematic Classifications
In addition to having Psychemedics stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
HealthcareUSA Equities from Healthcare industry as classified by Fama & French |
Psychemedics Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Psychemedics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Psychemedics backward and forwards among themselves. Psychemedics' institutional investor refers to the entity that pools money to purchase Psychemedics' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Santa Monica Partners Lp | 2023-12-31 | 20 K | Northern Trust Corp | 2023-12-31 | 15.3 K | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 3.5 K | Tower Research Capital Llc | 2023-12-31 | 2.3 K | Your Advocates Ltd., Llp | 2023-12-31 | 1.4 K | Fmr Inc | 2023-12-31 | 625 | Capital Advisors, Ltd. Llc | 2023-09-30 | 60.0 | Wells Fargo & Co | 2023-12-31 | 37.0 | Caldwell Sutter Capital Inc | 2023-12-31 | 30.0 | 22nw, Lp | 2023-12-31 | 274.4 K | Renaissance Technologies Corp | 2023-12-31 | 265.6 K |
Psychemedics Market Capitalization
The company currently falls under 'Micro-Cap' category with a total capitalization of 14.86 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Psychemedics's market, we take the total number of its shares issued and multiply it by Psychemedics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Psychemedics Profitablity
Psychemedics' profitability indicators refer to fundamental financial ratios that showcase Psychemedics' ability to generate income relative to its revenue or operating costs. If, let's say, Psychemedics is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Psychemedics' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Psychemedics' profitability requires more research than a typical breakdown of Psychemedics' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of (0.19) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.17) %, which entails that for every $100 of revenue, it lost $0.17. Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.31) | (0.30) | |
Return On Capital Employed | (0.34) | (0.32) | |
Return On Assets | (0.31) | (0.30) | |
Return On Equity | (0.62) | (0.59) |
Management Efficiency
Psychemedics has Return on Asset of (0.1176) % which means that on every $100 spent on assets, it lost $0.1176. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.4763) %, meaning that it generated no profit with money invested by stockholders. Psychemedics' management efficiency ratios could be used to measure how well Psychemedics manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.3. The current year's Return On Capital Employed is expected to grow to -0.32. At present, Psychemedics' Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 663.6 K, whereas Other Assets are forecasted to decline to about 1.2 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 1.16 | 1.50 | |
Net Current Asset Value | 0.00 | 0.00 | |
Tangible Asset Value | 0.00 | 0.00 | |
Tangible Book Value Per Share | 1.16 | 1.50 | |
Enterprise Value Over EBITDA | (69.02) | (65.57) | |
Price Book Value Ratio | 2.55 | 2.42 | |
Enterprise Value Multiple | (69.02) | (65.57) | |
Price Fair Value | 2.55 | 2.42 | |
Enterprise Value | 23.8 M | 44.4 M |
The analysis of Psychemedics' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Psychemedics' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Psychemedics Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Dividend Yield 0.1094 | Forward Dividend Yield 0.1094 | Forward Dividend Rate 0.28 | Beta 0.703 |
Technical Drivers
As of the 19th of April, Psychemedics holds the Coefficient Of Variation of (497.18), variance of 4.69, and Risk Adjusted Performance of (0.12). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Psychemedics, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We have collected data for thirteen technical drivers for Psychemedics, which can be compared to its competitors. Please check Psychemedics standard deviation, as well as the relationship between the maximum drawdown and kurtosis to decide if Psychemedics is priced some-what accurately, providing market reflects its current price of 2.54 per share. Please also confirm Psychemedics jensen alpha, which is currently at (0.47) to check out the company can sustain itself at a future point.Psychemedics Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Psychemedics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Psychemedics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Psychemedics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Psychemedics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Psychemedics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Psychemedics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Shoemaker Shannon over six months ago Psychemedics exotic insider transaction detected | ||
Weisenhoff Michael over six months ago Acquisition by Weisenhoff Michael of 4000 shares of Psychemedics subject to Rule 16b-3 | ||
Weisenhoff Michael over six months ago Psychemedics exotic insider transaction detected | ||
Michael Schaffer over six months ago Payment of 375 shares by Michael Schaffer of Psychemedics subject to Rule 16b-3 | ||
Michael Schaffer over six months ago Payment of 337 shares by Michael Schaffer of Psychemedics subject to Rule 16b-3 | ||
Fred Weinert over a year ago Acquisition by Fred Weinert of 1800 shares of Psychemedics subject to Rule 16b-3 |
Psychemedics Predictive Daily Indicators
Psychemedics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Psychemedics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Psychemedics Corporate Filings
8K | 28th of March 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 13th of February 2024 An amended filing to the original Schedule 13G | ViewVerify |
13A | 2nd of February 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 26th of January 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 24th of January 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F3 | 19th of December 2023 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
13A | 14th of December 2023 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
8K | 27th of November 2023 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Psychemedics Forecast Models
Psychemedics' time-series forecasting models are one of many Psychemedics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Psychemedics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Psychemedics Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Psychemedics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Psychemedics shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Psychemedics. By using and applying Psychemedics Stock analysis, traders can create a robust methodology for identifying Psychemedics entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (0.16) | (0.15) | |
Operating Profit Margin | (0.13) | (0.13) | |
Net Loss | (0.19) | (0.18) | |
Gross Profit Margin | 0.38 | 0.34 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Psychemedics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Dashboard Now
Portfolio DashboardPortfolio dashboard that provides centralized access to all your investments |
All Next | Launch Module |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Psychemedics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For information on how to trade Psychemedics Stock refer to our How to Trade Psychemedics Stock guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Psychemedics Stock analysis
When running Psychemedics' price analysis, check to measure Psychemedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Psychemedics is operating at the current time. Most of Psychemedics' value examination focuses on studying past and present price action to predict the probability of Psychemedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Psychemedics' price. Additionally, you may evaluate how the addition of Psychemedics to your portfolios can decrease your overall portfolio volatility.
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Global Correlations Find global opportunities by holding instruments from different markets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Fundamental Analysis View fundamental data based on most recent published financial statements |
Is Psychemedics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Psychemedics. If investors know Psychemedics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Psychemedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.30) | Dividend Share 0.07 | Earnings Share (0.72) | Revenue Per Share 3.85 | Quarterly Revenue Growth (0.12) |
The market value of Psychemedics is measured differently than its book value, which is the value of Psychemedics that is recorded on the company's balance sheet. Investors also form their own opinion of Psychemedics' value that differs from its market value or its book value, called intrinsic value, which is Psychemedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Psychemedics' market value can be influenced by many factors that don't directly affect Psychemedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Psychemedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Psychemedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Psychemedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.